BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38011940)

  • 1. Metabolic tumour volume in Hodgkin lymphoma-A comparison between manual and AI-based analysis.
    Sadik M; Barrington SF; Trägårdh E; Saboury B; Nielsen AL; Jakobsen AL; Gongora JLL; Urdaneta JL; Kumar R; Edenbrandt L
    Clin Physiol Funct Imaging; 2024 May; 44(3):220-227. PubMed ID: 38011940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMTV-Net: fully automated total metabolic tumor volume segmentation in lymphoma PET/CT images - a multi-center generalizability analysis.
    Yousefirizi F; Klyuzhin IS; O JH; Harsini S; Tie X; Shiri I; Shin M; Lee C; Cho SY; Bradshaw TJ; Zaidi H; Bénard F; Sehn LH; Savage KJ; Steidl C; Uribe CF; Rahmim A
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1937-1954. PubMed ID: 38326655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RECOMIA-a cloud-based platform for artificial intelligence research in nuclear medicine and radiology.
    Trägårdh E; Borrelli P; Kaboteh R; Gillberg T; Ulén J; Enqvist O; Edenbrandt L
    EJNMMI Phys; 2020 Aug; 7(1):51. PubMed ID: 32754893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an Automatic Classification Algorithm Using Convolutional Neural Networks in Oncological Positron Emission Tomography.
    Pinochet P; Eude F; Becker S; Shah V; Sibille L; Toledano MN; Modzelewski R; Vera P; Decazes P
    Front Med (Lausanne); 2021; 8():628179. PubMed ID: 33718406
    [No Abstract]   [Full Text] [Related]  

  • 5.
    Girum KB; Rebaud L; Cottereau AS; Meignan M; Clerc J; Vercellino L; Casasnovas O; Morschhauser F; Thieblemont C; Buvat I
    J Nucl Med; 2022 Dec; 63(12):1925-1932. PubMed ID: 35710733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep-Learning
    Capobianco N; Meignan M; Cottereau AS; Vercellino L; Sibille L; Spottiswoode B; Zuehlsdorff S; Casasnovas O; Thieblemont C; Buvat I
    J Nucl Med; 2021 Jan; 62(1):30-36. PubMed ID: 32532925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural network.
    Blanc-Durand P; Jégou S; Kanoun S; Berriolo-Riedinger A; Bodet-Milin C; Kraeber-Bodéré F; Carlier T; Le Gouill S; Casasnovas RO; Meignan M; Itti E
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1362-1370. PubMed ID: 33097974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of metabolic tumour volume on baseline
    Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First Extensive Analysis of
    Louarn N; Galicier L; Bertinchamp R; Lussato D; Montravers F; Oksenhendler É; Merlet P; Gérard L; Vercellino L
    J Clin Oncol; 2022 Apr; 40(12):1346-1355. PubMed ID: 35073166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma.
    Cottereau AS; Hapdey S; Chartier L; Modzelewski R; Casasnovas O; Itti E; Tilly H; Vera P; Meignan MA; Becker S
    J Nucl Med; 2017 Feb; 58(2):276-281. PubMed ID: 27754905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated classification of PET-CT lesions in lung cancer: An independent validation study.
    Borrelli P; Góngora JLL; Kaboteh R; Enqvist O; Edenbrandt L
    Clin Physiol Funct Imaging; 2022 Sep; 42(5):327-332. PubMed ID: 35760559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma.
    Decazes P; Becker S; Toledano MN; Vera P; Desbordes P; Jardin F; Tilly H; Gardin I
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1672-1679. PubMed ID: 29705879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non-small cell lung cancer treated with first-line pembrolizumab.
    Dall'Olio FG; Calabrò D; Conci N; Argalia G; Marchese PV; Fabbri F; Fragomeno B; Ricci D; Fanti S; Ambrosini V; Ardizzoni A
    Eur J Cancer; 2021 Jun; 150():99-107. PubMed ID: 33892411
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Morales-Lozano MI; Rodriguez-Otero P; Sancho L; Nuñez-Cordoba JM; Prieto E; Marcos-Jubilar M; Rosales JJ; Alfonso A; Guillen EF; San-Miguel J; Garcia-Velloso MJ
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated quantification of reference levels in liver and mediastinal blood pool for the Deauville therapy response classification using FDG-PET/CT in Hodgkin and non-Hodgkin lymphomas.
    Sadik M; Lind E; Polymeri E; Enqvist O; Ulén J; Trägårdh E
    Clin Physiol Funct Imaging; 2019 Jan; 39(1):78-84. PubMed ID: 30284376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.
    Cottereau AS; Versari A; Loft A; Casasnovas O; Bellei M; Ricci R; Bardet S; Castagnoli A; Brice P; Raemaekers J; Deau B; Fortpied C; Raveloarivahy T; Van Zele E; Chartier L; Vander Borght T; Federico M; Hutchings M; Ricardi U; Andre M; Meignan M
    Blood; 2018 Mar; 131(13):1456-1463. PubMed ID: 29437590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma.
    Toledano MN; Desbordes P; Banjar A; Gardin I; Vera P; Ruminy P; Jardin F; Tilly H; Becker S
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):680-688. PubMed ID: 29344718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic tumor burden on baseline
    Chen S; He K; Feng F; Wang S; Yin Y; Fu H; Wang H
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1830-1839. PubMed ID: 31187163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT Predict Outcomes in T-Cell Lymphoblastic Lymphoma.
    Feng X; Wen X; Li L; Sun Z; Li X; Zhang L; Wu J; Fu X; Wang X; Yu H; Ma X; Zhang X; Xie X; Han X; Zhang M
    Cancer Res Treat; 2021 Jul; 53(3):837-846. PubMed ID: 33285054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a convolution neural network for baseline total tumor metabolic volume on [
    Karimdjee M; Delaby G; Huglo D; Baillet C; Willaume A; Dujardin S; Bailliez A
    Eur Radiol; 2023 May; 33(5):3386-3395. PubMed ID: 36600126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.